Glenmark Pharmaceuticals

Ans. The current share price of Glenmark Pharmaceuticals is ₹2382.50.

Ans. Glenmark Pharmaceuticals operates in the Healthcare sector. Understanding the sector helps investors grasp market trends, which directly influence share prices.

Ans. The current P/E ratio of Glenmark Pharmaceuticals is ₹0. P/E ratio measures Glenmark Pharmaceuticals share price relative to its earnings per share, offering insight into the company's valuation.

Ans. The current P/B ratio of Glenmark Pharmaceuticals is ₹2.49. The Price-to-Book (P/B) ratio compares Glenmark Pharmaceuticals share price to its book value per share, indicating how much investors are willing to pay for each unit of net assets.

Ans. The 52-week high of Glenmark Pharmaceuticals is ₹2474.00, and the 52-week low is ₹1792.60. These 52-week high and low values help investors assess the stock's price volatility and trading opportunities.